Discover
CRBP
Corbus Pharmaceuticals Holdings, Inc.
9.07
1 x 8.80
1 x 10.44
bid
ask
-
0.31
3.30%
1 @ 04:41 AM
9.21 +0.14 (1.54%)
| Ytd | 11.43% | |
| 1y | 26.68% |
8.99
day range
9.45
7.12
52 week range
20.56
| Open | 9.29 | Prev Close | 9.38 | Low | 8.99 | High | 9.45 | Mkt Cap | 168.05M |
| Vol | 441.38K | Avg Vol | 485.48K | EPS | -5.74 | P/E | N/A | Forward P/E | -2.51 |
| Beta | 2.56 | Short Ratio | 8.28 | Inst. Own | 105.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 9.29 | 200-d Avg | 10.19 | 1yr Est | 56.78 |
| Income Statement | |||
| Operating Expenses | 24.30M | ||
| Research and Development Expense | 19.82M | ||
| Selling, General and Administrative Expense | 4.49M | ||
| Operating Income | -24.30M | ||
| Net Income | -22.97M | ||
| Net Income Common Stock | -22.97M | ||
| Net Income Common Stock (USD) | -22.97M | ||
| Consolidated Income | -22.97M | ||
| Earnings per Basic Share | -1.23 | ||
| Earnings per Basic Share (USD) | -1.23 | ||
| Earnings per Diluted Share | -1.23 | ||
| Earning Before Interest & Taxes (EBIT) | -22.97M | ||
| Earning Before Interest & Taxes (USD) | -22.97M | ||
| Weighted Average Shares | 18.71M | ||
| Weighted Average Shares Diluted | 18.71M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.05M | ||
| Cash and Equivalents (USD) | 26.05M | ||
| Investments | 112.56M | ||
| Investments Current | 112.56M | ||
| Current Assets | 143.57M | ||
| Property, Plant & Equipment Net | 914.00K | ||
| Total Assets | 144.48M | ||
| Debt Current | 1.21M | ||
| Total Debt | 1.21M | ||
| Current Liabilities | 18.14M | ||
| Total Liabilities | 18.14M | ||
| Accumulated Retained Earnings (Deficit) | -578.40M | ||
| Accumulated Other Comprehensive Income | -161.00K | ||
| Shareholders Equity | 126.34M | ||
| Shareholders Equity (USD) | 126.34M | ||
| Assets Non-Current | 914.00K | ||
| Total Debt (USD) | 1.21M | ||
| Trade and Non-Trade Payables | 435.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 49.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.12M | ||
| Capital Expenditure | -6.00K | ||
| Net Cash Flow from Investing | 22.46M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 22.46M | ||
| Net Cash Flow from Operations | -25.57M | ||
| Share Based Compensation | 1.92M | ||